开发针对线粒体的PARP抑制剂
Pavels Dimitrijevs1, Marina Makrecka-Kuka1, Pavel Arsenyan1
1Latvian Institute of Organic Synthesis, Aizkraukles 21, LV1006 Riga, Latvia.
Biomolecules
|January 28, 2026
概括
研究人员通过将现有药物与合物开发出针对线粒体的新型PARP抑制剂. 这些新化合物对缺乏BRCA1的乳腺癌细胞具有增强的功效,同时保持选择性.
科学领域:
- 在瘤学瘤学.
- 药用化学 医学化学
- 线粒体生物学 线粒体生物学
背景情况:
- 聚 ((ADP-ribose) 聚合酶 (PARP) 抑制剂是针对同类重组缺陷 (HRD) 瘤的已知抗癌药物.
- 针对细胞器特异性药物作用的线粒体仍然是一个挑战.
- 开发针对线粒体的PARP抑制剂可以提高有效性,并克服HRD癌症的耐药性.
研究的目的:
- 设计和合成针对线粒体的新型PARP抑制剂.
- 评估它们在线粒体中选择性积累和调节PARP活性的能力.
- 评估它们的抗癌疗效和选择性.
主要方法:
- 合成olaparib和rucaparib的试基 ((aryl) 联体.
- 在缺乏BRCA1的乳腺癌细胞 (HCC1937) 和非恶性心肌细胞 (H9C2) 中评估PARP1抑制,心脂蛋白结合亲和力和细胞毒性.
主要成果:
- 结合剂保留了强大的PARP1抑制 (IC50 = 3.4-17 nM).
- 特定衍生物 (2d,6c) 在HCC1937细胞中表现出强烈的心血管蛋白结合和增强的细胞毒性 (IC50 = 0.93,2.01μM),表现优于原始药物.
- 在H9C2细胞中减少的细胞毒性表明了有利的选择性特征.
结论:
- 酸结合成功地赋予了线粒体向PARP抑制剂的目标.
- 针对线粒体的PARP抑制剂显示出增强的抗癌效能和选择性.
- 这一策略有望为下一代针对HR缺陷瘤的治疗方法提供希望,有可能提高疗效并克服耐药性.
相关概念视频
Peroxisomes and Mitochondria
95.2K
Peroxisomes and mitochondria are two important oxygen-utilizing organelles in eukaryotic cells. Mitochondria carry out cellular respiration—the process that converts energy from food into ATP. Peroxisomes carry out a variety of functions, primarily breaking down different substances, such as fatty acids.
The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within...
The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within...
95.2K
Mitochondria
20.4K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
20.4K
Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Translocation of Proteins into the Mitochondria
13.4K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
13.4K
Dipeptidyl Peptidase 4 Inhibitors
644
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
644
Sustainable Development
15.1K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
15.1K


